Market Research

Europe Neuroendocrine Tumors Market - Industry Trends and Forecast to 2028

Lowest Prices Guaranteed Length Publisher Published Date SKU
from $3,500 210 Pages Data Bridge Market Research March, 2021 DAABD16625779
Lowest Prices Guaranteed
Price from $3,500
Length 210 Pages
Publisher Data Bridge Market Research
Published Date March, 2021
SKU DAABD16625779

Europe Neuroendocrine Tumors Market - Industry Trends and Forecast to 2028

Europe neuroendocrine tumors market is projected to register a CAGR of 10.2% in the forecast period of 2021 to 2028. The new market report contains data for the historic year 2019, the base year of calculation is 2020 and the forecast period is 2021 to 2028.
Market Segmentation:
Europe Neuroendocrine Tumors Market, By Classification (Functional Net and Non-Functional Net), Site (Lung, Pancreas, Gastrointestinal Tract (GI)), Grade (Grade 1 (Low-Grade Tumor, Grade 2 (Intermediate-Grade Tumor, Grade 3 (High-Grade Tumor)), Type (Diagnosis and Treatment), Route of Administration (Oral and Parenteral), End User (Hospitals, Specialty Clinics, Radiation Centers, Home Healthcare and Others), Distribution Channel (Direct Tender, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies and Others), Country (Germany, France, U.K., Hungary, Italy, Spain, Russia, Poland, Turkey, Switzerland, Netherlands, Belgium, Austria, Norway, Ireland, Lithuania, Rest of Europe) Industry Trends and Forecast to 2028

Some of the major factors contributing to the Europe neuroendocrine tumors market are:

• The increased mandate for targeted treatment therapies
• The rise in number of upcoming private cancer diagnostic centers and healthcare providers.

Market Players:

The key market players for Europe neuroendocrine tumors market are listed below:
• F. Hoffmann-La Roche Ltd
• Bristol-Myers Squibb Company
• Viatris Inc.
• Thermo Fisher Scientific Inc.
• Novartis AG
• Regeneron Pharmaceuticals, Inc.
• Sun Pharmaceutical Industries Ltd.
• Teva Pharmaceutical Industries Ltd.
• Eli Lilly and Company
• LUPIN
• Exact Sciences Corporation
• Pfizer Inc.
• Ipsen Pharma
• Advanced Accelerator Applications (a subsidiary of Novartis AG)
• Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.
• Bionano Genomics
• Illumina, Inc.
• GlaxoSmithKline plc
• Hutchison China MediTech Limited


Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Please note: This publisher does offer titles that are created upon receipt of order. The report will take approximately 15-20 business days to prepare and deliver.


1 Introduction
1.1 Objectives Of The Study
1.2 Market Definition
1.3 Overview Of The Europe Neuroendocrine Tumors Market
1.4 Currency And Pricing
1.5 Limitations
1.6 Markets Covered
2 Europe Neuroendocrine Tumors Market: Segmentation
2.1 Markets Covered
2.2 Geographical Scope
2.3 Years Considered For The Study
2.4 Dbmr Tripod Data Validation Model
2.5 Primary Interviews With Key Opinion Leaders
2.6 Multivariate Modelling
2.7 Classification Lifeline Curve
2.8 Dbmr Market Position Grid
2.9 Vendor Share Analysis
2.10 Market End User Coverage Grid
2.11 Secondary Sources
2.12 Assumptions
3 Executive Summary
4 Premium Insights
5 Pipeline Analysis
6 Pricing Analysis
7 Europe Neuroendocrine Tumors Market: Regulations
7.1 Regulatory Procedure In The U.S.
7.2 Regulatory Procedure In Canada
7.3 Regulatory Procedure In Europe
7.4 Regulatory Procedure In China
7.5 Regulatory Procedure In Middle East And Africa
8 Comparitive Analysis Between Monoclonal And Polyclonal Antibody
8.1 Monoclonal Antibody
8.2 Polyclonal Antibody
9 Market Overview
9.1 Drivers
9.1.1 Increased Incidence Of Neuroendocrine Tumor Cases
9.1.2 Technological Advancement For The Detection Of Neuroendocrine Tumors
9.1.3 Growth In The Number Of Private Diagnostic Centers And Treatment Providers
9.1.4 Presence Of Targeted Treatment Options
9.1.5 Favorable Reimbursement Policies
9.2 Restraints
9.2.1 High Capital Investments & Low Benefit-cost Ratio For Biomarkers And Orphan Drugs
9.2.2 Lack Of Awareness Among The Population
9.2.3 Unmet Needs And Access To Medical Resources In Several Regions
9.2.4 High Cost Of Diagnosis
9.3 Opportunities
9.3.1 Increased Government Initiatives
9.3.2 Emerging Therapies & Development In Treatment
9.3.3 Rising Collaborations Among The Market Players
9.4 Challenges
9.4.1 Side Effects Associated With Treatments
9.4.2 Stringent Government Regulations For The Development Of Neuroendocrine Tumor Drugs
10 Impact Of Covid 19 On Europe Neuroendocrine Tumors Market
10.1 Price Impact
10.2 Impact Of Demand
10.3 Impact On Supply Chain:
10.4 Strategic Decisions:
10.5 Conclusion:
11 Europe Neuroendocrine Tumors Market, By Classification
11.1 Overview
11.2 Non-functional Net
11.3 Funtional Net
12 Europe Neuroendocrine Tumors Market, By Site
12.1 Overview
12.2 Gastrointestinal Tract (Gi)
12.3 Lungs
12.4 Pancreas
13 Europe Neuroendocrine Tumors Market, By Grade
13.1 Overview
13.2 Grade 2 (Intermediate-grade Tumor)
13.3 Grade 3 (High-grade Tumor)
13.4 Grade 1( Low-grade Tumor)
14 Europe Neuroendocrine Tumors Market, By Type
14.1 Overview
14.2 Diagnosis
14.2.1 Blood Test
14.2.2 Imaging Test
14.2.2.1 Ctscan
14.2.2.2 Mri
14.2.2.3 Others
14.2.3 Biopsy
14.2.4 Urine Test
14.2.5 Others
14.3 Treatment
14.3.1 Somatostatin Analogs
14.3.1.1 Octreotide
14.3.1.2 Lanreotide
14.3.2 Targeted Therapy
14.3.2.1 Everolimus
14.3.2.2 Sunitinib
14.3.2.3 Others
14.3.3 Radiation Therapy
14.3.3.1 External-beam Radiation
14.3.3.2 Internal-beam Radiation
14.3.4 Surgery
14.3.4.1 Cholecystectomy
14.3.4.2 Others
14.3.5 Liver-directed Treatment
14.3.5.1 Radio Frequency Ablation (Rfa)
14.3.5.2 Hepatic Artery Embolization
14.3.5.3 Radioembolization
14.3.6 Peptide Receptor Radionuclide Therapy (Prrt)/ Lutathera
15 Europe Neuroendocrine Tumors Market, By Route Of Administration
15.1 Overview
15.2 Oral
15.2.1 Tablets
15.2.2 Pills
15.2.3 Others
15.3 Parenteral
15.3.1 Subcutaneous
15.3.2 Intramuscular
15.3.3 Others
16 Europe Neuroendocrine Tumors Market, By End User
16.1 Overview
16.2 Hospitals
16.3 Speciality Clinics
16.4 Radiation Centers
16.5 Home Healthcare
16.6 Others
17 Europe Neuroendocrine Tumors Market, By Distribution Channel
17.1 Overview
17.2 Direct Tender
17.3 Hospital Pharmacy
17.4 Retail Sales
17.5 Online Pharmacy
17.6 Others
18 Europe Neuroendocrine Tumors Market, By Geography
18.1 Europe
18.1.1 Germany
18.1.2 France
18.1.3 U.K.
18.1.4 Italy
18.1.5 Russia
18.1.6 Spain
18.1.7 Switzerland
18.1.8 Netherlands
18.1.9 Turkey
18.1.1 Ireland
18.1.2 Poland
18.1.3 Austria
18.1.4 Norway
18.1.5 Hungary
18.1.6 Lithuania
18.1.7 Rest Of Europe
19 Europe Neuroendocrine Tumors Market: Company Landscape
19.1 Company Share Analysis: Europe
20 Swot
21 Company Profiles
21.1 F. Hoffmann-la Roche Ltd
21.1.1 Company Snapshot
21.1.2 Revenue Analysis
21.1.3 Company Share Analysis
21.1.4 Product Portfolio
21.1.5 Recent Developments
21.2 Bristol-myers Squibb Company
21.2.1 Company Snapshot
21.2.2 Revenue Analysis
21.2.3 Company Share Analysis
21.2.4 Product Portfolio
21.2.5 Recent Developments
21.3 Viatris Inc.
21.3.1 Company Snapshot
21.3.2 Company Share Analysis
21.3.3 Product Portfolio
21.3.4 Recent Developments
21.4 Thermo Fisher Scientific Inc.
21.4.1 Company Snapshot
21.4.2 Revenue Analysis
21.4.3 Company Share Analysis
21.4.4 Product Portfolio
21.4.5 Recent Developments
21.5 Novartis Ag
21.5.1 Company Snapshot
21.5.2 Revenue Analysis
21.5.3 Company Share Analysis
21.5.4 Product Portfolio
21.5.5 Recent Developments
21.6 Regeneron Pharmaceuticals, Inc.
21.6.1 Company Snapshot
21.6.2 Revenue Analysis
21.6.3 Product Portfolio
21.6.4 Recent Developments
21.7 Advanced Accelerator Applications (A Subsidiary Of Novartis Ag)
21.7.1 Company Snapshot
21.7.2 Revenue Analysis
21.7.3 Product Portfolio
21.7.4 Recent Developments
21.8 Bionano Genomics
21.8.1 Company Snapshot
21.8.2 Product Portfolio
21.8.3 Recent Developments
21.9 Biosynthema Inc.
21.9.1 Company Snapshot
21.9.2 Product Portfolio
21.9.3 Recent Developments
21.10 Callistopharma
21.10.1 Company Snapshot
21.10.2 Product Portfolio
21.10.3 Recent Developments
21.11 Eli Lilly And Company
21.11.1 Company Snapshot
21.11.2 Revenue Analysis
21.11.3 Product Portfolio
21.11.4 Recent Developments
21.12 Exact Sciences Corporation
21.12.1 Company Snapshot
21.12.2 Revenue Analysis
21.12.3 Product Portfolio
21.12.4 Recent Developments
21.13 Glaxosmithkline Plc
21.13.1 Company Snapshot
21.13.2 Revenue Analysis
21.13.3 Product Portfolio
21.13.4 Recent Developments
21.14 Hutchison China Meditech Limited
21.14.1 Company Snapshot
21.14.2 Revenue Analysis
21.14.3 Product Portfolio
21.14.4 Recent Developments
21.15 Ipsen Pharma
21.15.1 Company Snapshot
21.15.2 Revenue Analysis
21.15.3 Product Portfolio
21.15.4 Recent Developments
21.16 Illumina, Inc.
21.16.1 Company Snapshot
21.16.2 Revenue Analysis
21.16.3 Product Portfolio
21.16.4 Recent Developments
21.17 Lupin
21.17.1 Company Snapshot
21.17.2 Revenue Analysis
21.17.3 Product Portfolio
21.17.4 Recent Developments
21.18 Merck Sharp & Dohme Corp., A Subsidiary Of Merck & Co., Inc.
21.18.1 Company Snapshot
21.18.2 Revenue Analysis
21.18.3 Product Portfolio
21.18.4 Recent Developments
21.19 Pfizer Inc.
21.19.1 Company Snapshot
21.19.2 Revenue Analysis
21.19.3 Product Portfolio
21.19.4 Recent Developments
21.20 Sun Pharmaceutical Industries Ltd.
21.20.1 Company Snapshot
21.20.2 Revenue Analysis
21.20.3 Product Portfolio
21.20.4 Recent Developments
21.21 Teva Pharmaceutical Industries Ltd.
21.21.1 Company Snapshot
21.21.2 Revenue Analysis
21.21.3 Product Portfolio
21.21.4 Recent Developments
22 Questionnaire
23 Related Reports
List Of Tables
Table 1 Europe Neuroendocrine Tumors Market, Pipeline Analysis
Table 2 Sales Data Of Oncology Market For 2019/
Table 3 Europe Neuroendocrine Tumors Market, By Classification 2019-2028(Usd Million)
Table 4 Europe Non-functional Net In Neuroendocrine Tumors Market, By Classification 2019-2027 (Usd Million)
Table 5 Europe Functional Net In Neuroendocrine Tumors Market, By Classification 2019-2027 (Usd Million)
Table 6 Europe Neuroendocrine Tumors Market, By Site 2019-2028 (Usd Million)
Table 7 Europe Gastrointestinal Tract (Gi) In Neuroendocrine Tumors Market, By Site 2019-2028 (Usd Million)
Table 8 Europe Lungs In Neuroendocrine Tumors Market, By Site 2019-2028 (Usd Million)
Table 9 Europe Pancreas Neuroendocrine Tumors Market, By Site 2019-2028 (Usd Million)
Table 10 Europe Neuroendocrine Tumors Market, By Grade 2019-2028 (Usd Million)
Table 11 Europe Grade 2 (Intermediate-grade Tumor) In Neuroendocrine Tumors Market, By Grade 2019-2028 (Usd Million)
Table 12 Europe Grade 3 (High-grade Tumor) In Neuroendocrine Tumors Market, By Grade 2019-2028 (Usd Million)
Table 13 Europe Neuroendocrine Tumors Market, By Grade 2019-2028 (Usd Million)
Table 14 Europe Neuroendocrine Tumors Market, By Type 2019-2028 (Usd Million)
Table 15 Europe Diagnosis In Neuroendocrine Tumors Market, By Type 2019-2028 (Usd Million)
Table 16 Europe Diagnosis In Neuroendocrine Tumors Market, By Type 2019-2028 (Usd Million)
Table 17 Europe Imaging Test In Neuroendocrine Tumors Market, By Type 2019-2028 (Usd Million)
Table 18 Europe Treatment Neuroendocrine Tumors Market, By Type 2019-2028 (Usd Million)
Table 19 Europe Treatment In Neuroendocrine Tumors Market, By Type 2019-2028 (Usd Million)
Table 20 Europe Somatostatin Analogs In Neuroendocrine Tumors Market, By Type 2019-2028 (Usd Million)
Table 21 Europe Targeted Therapy In Neuroendocrine Tumors Market, By Type 2019-2028 (Usd Million)
Table 22 Europe Radiation Therapy In Neuroendocrine Tumors Market, By Type 2019-2028 (Usd Million)
Table 23 Europe Surgery In Neuroendocrine Tumors Market, By Type 2019-2028 (Usd Million)
Table 24 Europe Liver-directed Treatment In Neuroendocrine Tumors Market, By Type 2019-2028 (Usd Million)
Table 25 Europe Neuroendocrine Tumors Market, By Route Of Administration, 2019-2028 (Usd Million)
Table 26 Europe Oral In Neuroendocrine Tumors Market, By Route Of Administration, 2019-2028 (Usd Million)
Table 27 Europe Oral In Neuroendocrine Tumors Market, By Route Of Administration, 2019-2028 (Usd Million)
Table 28 Europe Parenteral In Neuroendocrine Tumors Market, By Route Of Administration, 2019-2028 (Usd Million)
Table 29 Europe Parenteral In Neuroendocrine Tumors Market, By Route Of Administration, 2019-2028 (Usd Million)
Table 30 Europe Neuroendocrine Tumors Market, By End User, 2019-2028 (Usd Million)
Table 31 Europe Hospitals In Neuroendocrine Tumors Market, By End User, 2019-2028 (Usd Million)
Table 32 Europe Speciality Clinics In Neuroendocrine Tumors Market, By End User, 2019-2028 (Usd Million)
Table 33 Europe Radiation Centers In Neuroendocrine Tumors Market, By End User, 2019-2028 (Usd Million)
Table 34 Europe Others In Radiotherapy Market, By Region, 2018-2027 (Usd Million)
Table 35 Europe Others In Neuroendocrine Tumors Market, By End User, 2019-2028 (Usd Million)
Table 36 Europe Neuroendocrine Tumors Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 37 Europe Direct Tender In Neuroendocrine Tumors Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 38 Europe Hospital Pharmacy In Neuroendocrine Tumors Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 39 Europe Retail Sales In Neuroendocrine Tumors Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 40 Europe Online Pharmacy In Neuroendocrine Tumors Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 41 Europe Others In Neuroendocrine Tumors Market, By Distribution Channel, 2019-2028 (Usd Million)
Table 42 Europe Neuroendocrine Tumors Market, By Country, 2019-2028 (Usd Million)
Table 43 Europeneuroendocrine Tumors Market, By Classification, 2021-2028 (Usd Million )
Table 44 Europeneuroendocrine Tumors Market, By Site, 2021-2028 (Usd Million)
Table 45 Europeneuroendocrine Tumors Market, By Grade, 2021-2028 (Usd Million)
Table 46 Europeneuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 47 Europediagnosis In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million
Table 48 Europeimaging Test In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 49 Europetreatment In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 50 Europesomatostatin Analogs In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 51 Europetargeted Therapy In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 52 Europeradiation Therapy In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 53 Europesurgery In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 54 Europeliver Directed Treatment In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 55 Europeneuroendocrine Tumors Market, By Route Of Administration, 2021-2028 (Usd Million)
Table 56 Europeoral In Neuroendocrine Tumors Market, By Route Of Administration, 2021-2028 (Usd Million)
Table 57 Europeparenteral In Neuroendocrine Tumors Market, By Route Of Administration, 2021-2028 (Usd Million)
Table 58 Europeneuroendocrine Tumors Market, By End User, 2021-2028 (Usd Million)
Table 59 Europe Neuroendocrine Tumors Market, By Distribution Channel, 2021-2028 (Usd Million)
Table 60 Germany Neuroendocrine Tumors Market, By Classification, 2021-2028 (Usd Million )
Table 61 Germany Neuroendocrine Tumors Market, By Site, 2021-2028 (Usd Million)
Table 62 Germany Neuroendocrine Tumors Market, By Grade, 2021-2028 (Usd Million)
Table 63 Germanyneuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 64 Germanydiagnosis In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million
Table 65 Germany Imaging Test In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 66 Germany Treatment In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 67 Germany Somatostatin Analogs In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 68 Germany Targeted Therapy In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 69 Germany Radiation Therapy In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 70 Germany Surgery In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 71 Germanyliver Directed Treatment In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 72 Germanyneuroendocrine Tumors Market, By Route Of Administration, 2021-2028 (Usd Million)
Table 73 Germanyoral In Neuroendocrine Tumors Market, By Route Of Administration, 2021-2028 (Usd Million)
Table 74 Germanyparenteral In Neuroendocrine Tumors Market, By Route Of Administration, 2021-2028 (Usd Million)
Table 75 Germanyneuroendocrine Tumors Market, By End User, 2021-2028 (Usd Million)
Table 76 Germany Neuroendocrine Tumors Market, By Distribution Channel, 2021-2028 (Usd Million)
Table 77 France Neuroendocrine Tumors Market, By Classification, 2021-2028 (Usd Million )
Table 78 France Neuroendocrine Tumors Market, By Site, 2021-2028 (Usd Million)
Table 79 France Neuroendocrine Tumors Market, By Grade, 2021-2028 (Usd Million)
Table 80 France Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 81 France Diagnosis In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million
Table 82 France Imaging Test In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 83 Francetreatment In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 84 Francesomatostatin Analogs In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 85 Francetargeted Therapy In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 86 Franceradiation Therapy In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 87 Francesurgery In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 88 Franceliver Directed Treatment In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 89 Franceneuroendocrine Tumors Market, By Route Of Administration, 2021-2028 (Usd Million)
Table 90 Franceoral In Neuroendocrine Tumors Market, By Route Of Administration, 2021-2028 (Usd Million)
Table 91 Franceparenteral In Neuroendocrine Tumors Market, By Route Of Administration, 2021-2028 (Usd Million)
Table 92 Franceneuroendocrine Tumors Market, By End User, 2021-2028 (Usd Million)
Table 93 France Neuroendocrine Tumors Market, By Distribution Channel, 2021-2028 (Usd Million)
Table 94 U.K. Neuroendocrine Tumors Market, By Classification, 2021-2028 (Usd Million )
Table 95 U.K. Neuroendocrine Tumors Market, By Site, 2021-2028 (Usd Million)
Table 96 U.K. Neuroendocrine Tumors Market, By Grade, 2021-2028 (Usd Million)
Table 97 U.K. Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 98 U.K. Diagnosis In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million
Table 99 U.K. Imaging Test In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 100 U.K.Treatment In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 101 U.K.Somatostatin Analogs In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 102 U.K.Targeted Therapy In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 103 U.K.Radiation Therapy In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 104 U.K.Surgery In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 105 U.K.Liver Directed Treatment In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 106 U.K.Neuroendocrine Tumors Market, By Route Of Administration, 2021-2028 (Usd Million)
Table 107 U.K.Oral In Neuroendocrine Tumors Market, By Route Of Administration, 2021-2028 (Usd Million)
Table 108 U.K.Parenteral In Neuroendocrine Tumors Market, By Route Of Administration, 2021-2028 (Usd Million)
Table 109 U.K.Neuroendocrine Tumors Market, By End User, 2021-2028 (Usd Million)
Table 110 U.K. Neuroendocrine Tumors Market, By Distribution Channel, 2021-2028 (Usd Million)
Table 111 Italyneuroendocrine Tumors Market, By Classification, 2021-2028 (Usd Million )
Table 112 Italyneuroendocrine Tumors Market, By Site, 2021-2028 (Usd Million)
Table 113 Italyneuroendocrine Tumors Market, By Grade, 2021-2028 (Usd Million)
Table 114 Italyneuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 115 Italydiagnosis In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million
Table 116 Italyimaging Test In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 117 Italytreatment In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 118 Italysomatostatin Analogs In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 119 Italytargeted Therapy In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 120 Italyradiation Therapy In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 121 Italysurgery In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 122 Italyliver Directed Treatment In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 123 Italyneuroendocrine Tumors Market, By Route Of Administration, 2021-2028 (Usd Million)
Table 124 Italyoral In Neuroendocrine Tumors Market, By Route Of Administration, 2021-2028 (Usd Million)
Table 125 Italyparenteral In Neuroendocrine Tumors Market, By Route Of Administration, 2021-2028 (Usd Million)
Table 126 Italyneuroendocrine Tumors Market, By End User, 2021-2028 (Usd Million)
Table 127 Italy Neuroendocrine Tumors Market, By Distribution Channel, 2021-2028 (Usd Million)
Table 128 Russia Neuroendocrine Tumors Market, By Classification, 2021-2028 (Usd Million )
Table 129 Russianeuroendocrine Tumors Market, By Site, 2021-2028 (Usd Million)
Table 130 Russianeuroendocrine Tumors Market, By Grade, 2021-2028 (Usd Million)
Table 131 Russianeuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 132 Russiadiagnosis In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million
Table 133 Russiaimaging Test In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 134 Russiatreatment In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 135 Russiasomatostatin Analogs In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 136 Russiatargeted Therapy In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 137 Russiaradiation Therapy In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 138 Russiasurgery In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 139 Russialiver Directed Treatment In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 140 Russianeuroendocrine Tumors Market, By Route Of Administration, 2021-2028 (Usd Million)
Table 141 Russiaoral In Neuroendocrine Tumors Market, By Route Of Administration, 2021-2028 (Usd Million)
Table 142 Russiaparenteral In Neuroendocrine Tumors Market, By Route Of Administration, 2021-2028 (Usd Million)
Table 143 Russianeuroendocrine Tumors Market, By End User, 2021-2028 (Usd Million)
Table 144 Russia Neuroendocrine Tumors Market, By Distribution Channel, 2021-2028 (Usd Million)
Table 145 Spain Neuroendocrine Tumors Market, By Classification, 2021-2028 (Usd Million )
Table 146 Spain Neuroendocrine Tumors Market, By Site, 2021-2028 (Usd Million)
Table 147 Spain Neuroendocrine Tumors Market, By Grade, 2021-2028 (Usd Million)
Table 148 Spain Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 149 Spaindiagnosis In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million
Table 150 Spainimaging Test In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 151 Spaintreatment In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 152 Spainsomatostatin Analogs In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 153 Spaintargeted Therapy In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 154 Spainradiation Therapy In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 155 Spainsurgery In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 156 Spainliver Directed Treatment In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 157 Spain Neuroendocrine Tumors Market, By Route Of Administration, 2021-2028 (Usd Million)
Table 158 Spainoral In Neuroendocrine Tumors Market, By Route Of Administration, 2021-2028 (Usd Million)
Table 159 Spainparenteral In Neuroendocrine Tumors Market, By Route Of Administration, 2021-2028 (Usd Million)
Table 160 Spain Neuroendocrine Tumors Market, By End User, 2021-2028 (Usd Million)
Table 161 Spain Neuroendocrine Tumors Market, By Distribution Channel, 2021-2028 (Usd Million)
Table 162 Switzerland Neuroendocrine Tumors Market, By Classification, 2021-2028 (Usd Million )
Table 163 Switzerland Neuroendocrine Tumors Market, By Site, 2021-2028 (Usd Million)
Table 164 Switzerlandneuroendocrine Tumors Market, By Grade, 2021-2028 (Usd Million)
Table 165 Switzerlandneuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 166 Switzerlanddiagnosis In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million
Table 167 Switzerlandimaging Test In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 168 Switzerlandtreatment In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 169 Switzerlandsomatostatin Analogs In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 170 Switzerlandtargeted Therapy In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 171 Switzerlandradiation Therapy In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 172 Switzerlandsurgery In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 173 Switzerlandliver Directed Treatment In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 174 Switzerlandneuroendocrine Tumors Market, By Route Of Administration, 2021-2028 (Usd Million)
Table 175 Switzerlandoral In Neuroendocrine Tumors Market, By Route Of Administration, 2021-2028 (Usd Million)
Table 176 Switzerlandparenteral In Neuroendocrine Tumors Market, By Route Of Administration, 2021-2028 (Usd Million)
Table 177 Switzerlandneuroendocrine Tumors Market, By End User, 2021-2028 (Usd Million)
Table 178 Switzerland Neuroendocrine Tumors Market, By Distribution Channel, 2021-2028 (Usd Million)
Table 179 Netherlands Neuroendocrine Tumors Market, By Classification, 2021-2028 (Usd Million )
Table 180 Netherlands Neuroendocrine Tumors Market, By Site, 2021-2028 (Usd Million)
Table 181 Netherlands Neuroendocrine Tumors Market, By Grade, 2021-2028 (Usd Million)
Table 182 Netherlands Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 183 Netherlands Diagnosis In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million
Table 184 Netherlands Imaging Test In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 185 Netherlands Treatment In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 186 Netherlands Somatostatin Analogs In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 187 Netherlands Targeted Therapy In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 188 Netherlands Radiation Therapy In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 189 Netherlands Surgery In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 190 Netherlands Liver Directed Treatment In Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)
Table 191 Netherlands Neuroendocrine Tumors Market, By Route Of Administration, 2021-2028 (Usd Million)
Table 192 Netherlands Oral In Neuroendocrine Tumors Market, By Route Of Administration, 2021-2028 (Usd Million)
Table 193 Netherlands Parenteral In Neuroendocrine Tumors Market, By Route Of Administration, 2021-2028 (Usd Million)
Table 194 Netherlands Neuroendocrine Tumors Market, By End User, 2021-2028 (Usd Million)
Table 195 Netherlands Neuroendocrine Tumors Market, By Distribution Channel, 2021-2028 (Usd Million)
Table 196 Turkey Neuroendocrine Tumors Market, By Classification, 2021-2028 (Usd Million)
Table 197 Turkey Neuroendocrine Tumors Market, By Site, 2021-2028 (Usd Million)
Table 198 Turkey Neuroendocrine Tumors Market, By Grade, 2021-2028 (Usd Million)
Table 199 Turkey Neuroendocrine Tumors Market, By Type, 2021-2028 (Usd Million)

$3,500
$4,200

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings